Myriad Genetics | MYGN - Ebit


Myriad Genetics reported $-3M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Agilent USD 444M 45M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Bio-Rad Laboratories USD 72.6M 750.1M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Danaher USD 1.25B 118M Sep/2026
Illumina USD 305M 45M Sep/2026
J&J USD 6.47B 1B Sep/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Quidel USD -15.3M 12.1M Jun/2026
Repligen USD 24.31M 3.18M Sep/2026
Revvity USD 126.14M 43.36M Jun/2026
Standard Biotools USD -7.83M 1.59M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Veracyte USD 23.96M 4.88M Jun/2026
Waters USD 10M 138M Jun/2026